Mustafa Bahadır Can Balcı

Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia

Mine Kücür, Ferruh Kemal İşman, Mustafa Bahadır Can Balcı et al. · Urologic Oncology Seminars and Original Investigations · 2008 · 49 citations

Urology, Medicine, Pathology +5

Intravesical Prostatic Protrusion: A Potential Marker of Alpha-blocker Treatment Success in Patients With Benign Prostatic Enlargement

Arif Kalkanlı, Zafer Tandoğdu, Alaettin Sener Karaca et al. · Urology · 2015 · 38 citations

Urology, Benign Prostatic Enlargement, Alpha-blocker Treatment Success +6

Does Structured Withdrawal of Desmopressin Improve Relapse Rates in Patients with Monosymptomatic Enuresis?

Mehmet İlker Gökçe, Parviz Hajıyev, Evren Süer et al. · The Journal of Urology · 2014 · 35 citations

Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study

Zafer Tandoğdu, Béla Köves, Slobodan Ristovski et al. · World Journal of Urology · 2024 · 22 citations · Full text

The Role of Bipolar Transurethral Vaporization in the Management of Benign Prostatic Hyperplasia

Barış Nuhoğlu, Mustafa Bahadır Can Balcı, İsmet Hazar et al. · Urologia Internationalis · 2011 · 18 citations